Astria Therapeutics, Inc. Balance Sheet
ATXS / Health Care|12 years of annual SEC 10-K data (FY2013-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 12 fiscal years. All figures from audited SEC 10-K filings.
Astria Therapeutics, Inc. had $342M in total assets and $319M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $59.8M | $175.5M | $20.5M | $86.5M | $24.9M | $9.9M | $15.3M | $16.4M | $23.6M | $62.8M | $14.7M | $30.5M |
| Current Assets | $334.6M | $250.9M | $227.7M | $127.1M | $46.3M | $39.0M | $38.9M | $17.5M | $39.5M | $63.6M | $15.0M | - |
| PP&E (Net) | - | - | - | - | - | - | $56.0K | $321.0K | $568.0K | $504.0K | $288.0K | - |
| Total Assets | $342.4M | $254.7M | $230.6M | $127.5M | $47.5M | $41.8M | $39.2M | $17.9M | $40.2M | $64.2M | $16.0M | - |
| Current Liabilities | $19.1M | $11.6M | $9.1M | $5.2M | $6.4M | $5.0M | $4.2M | $6.0M | $8.3M | $7.8M | $4.2M | - |
| Total Debt | - | - | - | - | - | - | - | $2.5M | $5.8M | - | - | - |
| Shareholders' Equity | $319.3M | $243.1M | $221.2M | $122.3M | $40.7M | $35.7M | $34.9M | $11.8M | $29.1M | $50.5M | -$73.1M | -$52.2M |